These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 289867)

  • 1. Angiotensin II blockade by saralasin in the evaluation of hypertension in children.
    Favre L; Boerth RC; Braren V; Dean RH; Hollifield JW
    Kidney Int Suppl; 1979 Mar; (9):S75-82. PubMed ID: 289867
    [No Abstract]   [Full Text] [Related]  

  • 2. Angiotensin II blockade: evidence for baroreceptor-mediated renin release and the role of sodium balance.
    Baer L; Parra-Carrillo JZ; Radichevich I
    Kidney Int Suppl; 1979 Mar; (9):S60-7. PubMed ID: 289865
    [No Abstract]   [Full Text] [Related]  

  • 3. [Renovascular hypertension: prediction of surgical treatment by angiotensin II blockade and saralasin (author's transl)].
    Mimran A; Deschodt G; Barjon P; Mary H; Thevenet A
    Nouv Presse Med; 1978 Dec; 7(43):3889-93. PubMed ID: 733540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of 12-hour infusions of saralasin or captopril on blood pressure in hypertensive conscious rats. Relationship to plasma renin, duration of hypertension, and effect of unclipping.
    Bing RF; Russell GI; Swales JD; Thurston H
    J Lab Clin Med; 1981 Aug; 98(2):302-10. PubMed ID: 7019368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Saralasin and prediction of the surgical result in renovascular arterial hypertension].
    Mimran A; Deschodt G; Fourcade J; Barjon P
    Arch Mal Coeur Vaiss; 1979 Nov; 72 Spec no():16-21. PubMed ID: 119507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Saralasin in human hypertension: the early experience.
    Brunner HR; Laragh JH
    Kidney Int Suppl; 1979 Mar; (9):S36-43. PubMed ID: 289862
    [No Abstract]   [Full Text] [Related]  

  • 7. Use of saralasin in end-stage renal disease.
    Fadem SZ; Lifschitz MD
    Kidney Int Suppl; 1979 Mar; (9):S93-100. PubMed ID: 289869
    [No Abstract]   [Full Text] [Related]  

  • 8. Angiotensin as a renal, adrenal, and cardiovascular hormone: responses to saralasin in normal man and in essential and secondary hypertension.
    Hollenberg NK; Williams GH
    Kidney Int Suppl; 1979 Mar; (9):S29-35. PubMed ID: 384070
    [No Abstract]   [Full Text] [Related]  

  • 9. Angiotensin blockade in postoperative paradoxical hypertension of coarctation of the aorta.
    Farrell BG; Parker FB; Poirier RA; Anderson G; Streeten DH; Blackman M
    Surg Forum; 1979; 30():189-90. PubMed ID: 395680
    [No Abstract]   [Full Text] [Related]  

  • 10. Angiotensin II profiling with saralasin: summary of Eaton collaborative study.
    Horne ML; Conklin VM; Keenan RE; Varady PD; DiNardo J
    Kidney Int Suppl; 1979 Mar; (9):S115-122. PubMed ID: 289860
    [No Abstract]   [Full Text] [Related]  

  • 11. Laboratory tests in the evaluation of renal hypertension.
    Vaughan ED
    Urol Clin North Am; 1979 Oct; 6(3):485-502. PubMed ID: 388789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Significance of the saralasin infusion test in the diagnosis of arterial hypertension].
    Glorioso N; Madeddu P; Dessì-Fulgheri P; Meloni F; Palermo M; Fiori C; Rappelli A
    Boll Soc Ital Cardiol; 1980; 25(9):1035-46. PubMed ID: 7025868
    [No Abstract]   [Full Text] [Related]  

  • 13. Evaluation of surgical response in renovascular hypertension using angiotensin II blockade.
    Buda JA; Baer L; Arora SP; Parra-Carrillo JZ; Radichevich I
    Surgery; 1978 Nov; 84(5):664-70. PubMed ID: 715682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Saralasin infusion in renovascular and essential hypertension.
    Thien T; Hoefnagels WH
    Neth J Med; 1980; 23(2):68-73. PubMed ID: 6990282
    [No Abstract]   [Full Text] [Related]  

  • 15. Use of angiotensin antagonists in experimental and human renovascular hypertension.
    Maxwell MH
    Adv Nephrol Necker Hosp; 1979; 8():297-319. PubMed ID: 115245
    [No Abstract]   [Full Text] [Related]  

  • 16. Outpatient experience with saralasin.
    Streeten DH; Anderson GH
    Kidney Int Suppl; 1979 Mar; (9):S44-52. PubMed ID: 289863
    [No Abstract]   [Full Text] [Related]  

  • 17. Reactive hyperreninemia in renovascular hypertension after angiotensin blockage with saralasin or converting enzyme inhibitor.
    Case DB; Laragh JH
    Ann Intern Med; 1979 Aug; 91(2):153-60. PubMed ID: 464461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypertension screening and treatment with angiotensin inhibitors. Saralasin and captopril.
    Zawada ET; Stinson J; Ramirez G
    Postgrad Med; 1980 Oct; 68(4):89-92, 94-5, 98. PubMed ID: 6999479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of saralasin to detect renovascular hypertension in childhood.
    Gillespie L; Ehrlich RM; Marks LS; Maxwell MH; Kaufman JJ
    Urology; 1980 Nov; 16(5):453-6. PubMed ID: 7003900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin blockade by saralasin bolus injection.
    Maxwell MH; Marks LS
    Kidney Int Suppl; 1979 Mar; (9):S53-9. PubMed ID: 289864
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.